Department of Pharmacy, School of Health and Allied Science, Pokhara University, PO Box 427, Dhungepatan, Kaski, Nepal.
Phytother Res. 2017 Apr;31(4):568-578. doi: 10.1002/ptr.5784. Epub 2017 Feb 10.
Cancer is a pathological condition where excessive and abnormal cell growth leads to widespread invasion within the body to affect various organ functions. It is known that chemotherapeutic agents are themselves possible candidate of cancer generation as they can kill normal cells. So, therapeutic approach for cancer treatment and prevention is weighed in terms of benefit to risk ratio. Nowadays, there is an immense interest for the search herbal formulation with cancer preventive effect because of the problems, generated with existing chemotherapeutic regimens. Research interest in fruits rich in polyphenols is increasing because of their anticancer potential. In this review, we highlight the potential health benefits of pomegranate (Punica granatum) fruit and the underlying mechanism of its inhibition of cancer progression. Pomegranate has demonstrated anti-proliferative, anti-metastatic and anti-invasive effects on various cancer cell line in vitro as well as in vivo animal model or human clinical trial. Although several clinical trials are in progress for identifying the pomegranate as a candidate for various cancer treatment. It is necessary to replicate and validate its therapeutic efficacy by multiple clinical studies in order to formulate pomegranate products as an integral part of the dietary and pharmacological intervention in anticancer therapy. Copyright © 2017 John Wiley & Sons, Ltd.
癌症是一种病理状况,其中过度和异常的细胞生长导致广泛的体内侵袭,影响各种器官功能。已知化疗药物本身可能是癌症发生的候选物,因为它们可以杀死正常细胞。因此,癌症治疗和预防的治疗方法是根据效益风险比来权衡的。由于现有化疗方案所产生的问题,目前人们对具有癌症预防作用的草药制剂的研究产生了浓厚的兴趣。由于其抗癌潜力,富含多酚的水果的研究兴趣正在增加。在这篇综述中,我们强调了石榴(Punica granatum)果实的潜在健康益处及其抑制癌症进展的潜在机制。石榴在体外以及体内动物模型或人体临床试验中对各种癌细胞系表现出抗增殖、抗转移和抗侵袭作用。尽管正在进行几项临床试验以确定石榴作为各种癌症治疗候选物。有必要通过多项临床研究复制和验证其治疗效果,以便将石榴产品作为饮食和药理学干预抗癌治疗的一个组成部分。版权所有©2017 约翰威立父子公司